|
Survival outcomes of Black/African American (B/AA) patients with HER2-negative (IHC 0, 1+, 2+ and ISH-), advanced breast cancer (HER2-neg aBC) across three academic cancer centers in the United States. |
| |
|
Research Funding - AstraZeneca (Inst); GRAIL (Inst); SpringWorks Therapeutics (Inst) |
| |
|
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst) |
| |
|
Employment - 14th Street Medical (I) |
Consulting or Advisory Role - Aprea Therapeutics; InSilico Medicine; Salarius Pharmaceuticals |
Research Funding - AstraZeneca (Inst); Bayer (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - AstraZeneca (Inst) |
| |
|
Consulting or Advisory Role - Immunogen |
Speakers' Bureau - Immunogen |
Research Funding - Mersana |
Travel, Accommodations, Expenses - Immunogen |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
Research Funding - AstraZeneca |
| |
|
No Relationships to Disclose |
| |
|
Employment - Daiichi Sankyo |
Stock and Other Ownership Interests - Daiichi Sankyo |
| |
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
| |
|
|
Consulting or Advisory Role - Millcreek Outcomes Group; MJH Healthcare Holdings, LLC; Otsuka; Pfizer; Sanofi; Tandem Diabetes Care |
Speakers' Bureau - Leo Pharma |
Research Funding - AstraZeneca; Bayer; SpringWorks Therapeutics |
| |
|
Stock and Other Ownership Interests - Salarius Pharmaceuticals |
Consulting or Advisory Role - Bristol-Myers Squibb; Dracen; Iterion Therapeutics; Molecular Templates; Salarius Pharmaceuticals; SonaCare Medical |
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bioverativ (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst) |